Figure 2.
Cumulative recurrence-free survival (RFS) following initial treatment for hepatocellular carcinoma for all cases (n=74). The 1-, 3- and 5-year cumulative RFS rates were 82.8, 52.1 and 25.6%, respectively.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.